Literature DB >> 7285505

Novel double-isotope technique for enzymatic assay of catecholamines, permitting high precision, sensitivity and plasma sample capacity.

M J Brown, D A Jenner.   

Abstract

1. A novel use of a double-isotope method is described which allows radioenzymatic assays to combine precision and sensitivity. 2. In the catechol O-methyltransferase assay separate portions of each plasma sample are incubated with either S-[3H]- or S-[14C]-adenosyl-L-methionine. Standards of noradrenaline and adrenaline are added to the latter portions and are thus converted into standards of [14C]metadrenalines. These are added to the 3H-labelled portions after the incubation, where they function as tracers. 3. The final recovery of 14C radioactivity corrects for (a) the efficiency of methylation in the plasma sample concerned and (b) the recovery of metadrenalines during the extraction procedures. 4. The 3H/14C ratio is constant in each assay for a given catecholamine concentration and is determined for samples to which standards of noradrenaline and adrenaline are added to the 3H- (as well as the 14C-) labelled portions before the initial incubation. 5. The sensitivity of the assay is increased by using high specific radioactivity S-[3H]adenosyl-L-methionine (60--85 Ci/mmol), and low backgrounds are maintained by catecholamine depletion in vivo in the rats use for enzyme preparation. 6. Both catecholamines (1.5 pg/ml; 10 pmol/l) may be detected; the coefficients of variation are 3.0 and 3.2% for noradrenaline and adrenaline respectively (intra-assay) and 4.6 and 5.0% (inter-assay).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7285505     DOI: 10.1042/cs0610591

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  52 in total

1.  Phaeochromocytoma with associated somatostatin production.

Authors:  A H Morice; J S Price; M J Ashby; M J Brown
Journal:  BMJ       Date:  1989-05-20

2.  The physiological and pharmacological role of presynaptic alpha- and beta-adrenoceptors in man.

Authors:  M J Brown; A D Struthers; J M Burrin; L Di Silvio; D C Brown
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

3.  Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone.

Authors:  A Grove; L C McFarlane; B J Lipworth
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

4.  Temperature response to severe head injury and the effect on body energy expenditure and cerebral oxygen consumption.

Authors:  D S Matthews; R E Bullock; J N Matthews; A Aynsley-Green; J A Eyre
Journal:  Arch Dis Child       Date:  1995-06       Impact factor: 3.791

5.  Attenuation by diltiazem of arterial baroreflex sensitivity in man.

Authors:  J F Giudicelli; A Berdeaux; A Edouard; F Lhoste; C Richer; C Thuillez; A Jacolot
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Acute neurohormonal responses to hypoxaemia in man.

Authors:  R I Cargill; L C McFarlane; W J Coutie; B J Lipworth
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

7.  The effect of angiotensin II and noradrenaline alone and in combination on renal sodium excretion in man.

Authors:  P H Seidelin; J J McMurray; R A Brown; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

8.  Lithium does not alter the renal response to a pressor dose of tyramine in man.

Authors:  C C Lang; A R Rahman; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

9.  Concentration effect relationships of infused histamine in normal volunteers.

Authors:  P W Ind; M J Brown; F J Lhoste; I Macquin; C T Dollery
Journal:  Agents Actions       Date:  1982-04

10.  Serum amino acid profiles and dopamine in schizophrenic patients and healthy subjects: Window to the brain?

Authors:  M L Rao; B Strebel; G Gross; G Huber
Journal:  Amino Acids       Date:  1992-02       Impact factor: 3.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.